We are live on ! Find out more
SXTP icon

60 Degrees Pharmaceuticals
SXTP

7 hedge funds and large institutions have $127K invested in 60 Degrees Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

133% more funds holding

Funds holding: 3 → 7 (+4)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.03% → 0.02% (-0.01%)

73% less capital invested

Capital invested by funds: $467K → $127K (-$341K)

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$46.7K
2
VF
Virtu Financial
New York
+$27.7K
3
TSS
Two Sigma Securities
New York
+$11.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.24K
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.8K

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$104K
2
CBT
Central Bank & Trust
Kentucky
-$41.4K

SXTP Hedge Fund Activity: Q1 2024 in Review

7 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q1 2024, worth a combined $127K — down 73% from $467K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SXTP positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $46.7K. The largest seller was Walleye Capital, exiting entirely with an estimated $104K sold.

  • 7 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q1 2024, up from 3 in Q4 2023.
  • Funds reported $127K of 60 Degrees Pharmaceuticals stock for Q1 2024, down 73% quarter-over-quarter.
  • 5 funds opened new 60 Degrees Pharmaceuticals positions in Q1 2024 and 1 closed out, a net change of +4 holders.
  • The largest 60 Degrees Pharmaceuticals buyer in Q1 2024 was Citadel Advisors, an estimated $46.7K added.
  • The largest 60 Degrees Pharmaceuticals seller in Q1 2024 was Walleye Capital, an estimated $104K sold.

Based on aggregated 13F filings for Q1 2024.